Navigated macular laser decreases retreatment rate for diabetic macular edema: A comparison with conventional macular laser

Clinical Ophthalmology

Volumn 7, Issue 1, 2013, Pages 121-128

  Neubauer, Aljoscha S ^a   Langer, Julian ^a   Liegl, Raffael ^a   Haritoglou, Christos ^a   Wolf, Armin ^a   Kozak, Igor ^b   Seidensticker, Florian ^a   Ulbig, Michael ^a   Freeman, William R ^b   Kampik, Anselm ^a   Kernt, Marcus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes mellitus; Diabetic macular edema; Diabetic retinopathy; Macular laser; Navigated focal laser; Navilas

Indexed keywords

ADULT; ARTICLE; BEST CORRECTED VISUAL ACUITY; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; FEMALE; HUMAN; INTERVENTION STUDY; LASER COAGULATION; LOW LEVEL LASER THERAPY; MALE; MULTICENTER STUDY; NEODYMIUM YAG LASER; OUTCOME ASSESSMENT; PILOT STUDY; PROPENSITY SCORE; PROSPECTIVE STUDY; RETREATMENT; SURVIVAL RATE; VISUAL ACUITY;

EID: 84872732004     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S38559     Document Type: Article

References (33)

1. Klein R, Klein BE, Moss SE. The Wisconsin Epidemiological Study of Diabetic Retinopathy: a review. Diabetes Metab Rev. 1989;5:559-570.
2. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epide-miologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology. 1995;102:716.
3. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema. Ophthalmology. 1984;91:1464-1474.
4. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009;116:497-503.
5. Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XI. The incidence of macular edema. Ophthalmology. 1989;96:1501-1510.
6. Chen E, Looman M, Laouri M, et al. Burden of illness of diabetic macular edema: literature review. Curr Med Res Opin. 2010;26:1587-1597.
7. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
8. Elman MJ, Bressler NM, Qin H, et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2011;118:609-614.
9. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118: 615-625.
10. Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the ranibizumab for edema of the macular in diabetes (READ-2) study. Ophthalmology. 2010;117:2146-2151.
11. Stewart MW. Anti-vascular endothelial growth factor drug treatment of diabetic macular edema: the evolution continues. Curr Diabetes Rev. 2012;8:237-246.
12. Beck RW, Edwards AR, Aiello LP, et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intra-vitreal triamcinolone for diabetic macular edema. Arch Ophthalmol. 2009;127:245-251.
13. Bandello F, Cunha-Vaz J, Chong NV, et al. New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel. Eye (Lond). 2012;26:485-493.
14. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1987;94:761-774.
15. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis. Curr Opin Ophthalmol. 2000;11:175-179.
16. Smiddy WE. Economic considerations of macular edema therapies. Ophthalmology. 2011;118:1827-1833.
17. Campbell CJ, Noyori KS, Rittler MC, Innis RE, Koester CJ. The appli-cation of fiber laser techniques to retinal surgery. Arch Ophthalmol. 1964;72:850-857.
18. Meyer-Schwickerath G. Light coagulation; a method for treatment and prevention of the retinal detachment. Albrecht Von Graefes Arch Ophthalmol. 1954;156:2-34. German.
19. Neubauer AS, Ulbig MW. Laser treatment in diabetic retinopathy. Ophthalmologica. 2007;221:95-102.
20. Velez-Montoya R, Guerrero-Naranjo JL, Gonzalez-Mijares CC, et al. Pattern scan laser photocoagulation: safety and complications, experience after 1301 consecutive cases. Br J Ophthalmol. 2010;94:720-724.
21. Nakamura Y, Mitamura Y, Ogata K, Arai M, Takatsuna Y, Yamamoto S. Functional and morphological changes of macula after subthreshold micropulse diode laser photocoagulation for diabetic macular oedema. Eye (Lond). 2010;24:784-748.
22. Bolz M, Kriechbaum K, Simader C, et al. In vivo retinal morphology after grid laser treatment in diabetic macular edema. Ophthalmology. 2010;117:538-544.
23. Kernt M, Cheuteu R, Vounotrypidis E, et al. Focal and panretinal photocoagulation with a navigated laser (Navilas). Acta Ophthalmol. 2011;89:e662-e664.
24. Kozak I, Kim JS, Oster SF, Chhablani J, Freeman WR. Focal navigated laser photocoagulation in retinovascular disease: clinical results in initial case series. Retina. 2012;32:930-935.
25. Kozak I, Oster SF, Cortes MA, et al. Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagula-tor Navilas. Ophthalmology. 2011;118:1119-1124.
26. Johnson ML, Bush RL, Collins TC, et al. Propensity score analysis in observational studies: outcomes after abdominal aortic aneurysm repair. Am J Surg. 2006;192:336-343.
27. McCaffrey DF, Ridgeway G, Morral AR. Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods. 2004;9:403-425.
28. Silber JH, Rosenbaum PR, Trudeau ME, et al. Multivariate matching and bias reduction in the surgical outcomes study. Med Care. 2001;39:1048-1064.
29. Landrum MB, Guadagnoli E, Zummo R, Chin D, McNeil BJ. Care following acute myocardial infarction in the Veterans Administra-tion Medical Centers: a comparison with Medicare. Health Serv Res. 2004;39:1773-1792.
30. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report no 1. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 1985;103(12): 1796-1806.
31. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report no 4. The Early Treatment Diabetic Retinopa-thy Study Research Group. Int Ophthalmol Clin. 1987;27:265-272.
32. Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117: 1064-1077.
33. Fong DS, Strauber SF, Aiello LP, et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol. 2007;125:469-480.